Levetiracetam administration for the management of levodopa-induced dyskinesias in Parkinson's disease: a double-blind, placebo-controlled, crossover trial.

Trial Profile

Levetiracetam administration for the management of levodopa-induced dyskinesias in Parkinson's disease: a double-blind, placebo-controlled, crossover trial.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 31 Oct 2014

At a glance

  • Drugs Levetiracetam (Primary)
  • Indications Drug-induced dyskinesia; Parkinson's disease
  • Focus Therapeutic Use
  • Acronyms VALID-PD
  • Most Recent Events

    • 14 Nov 2007 Status changed from recruiting to in progress.
    • 12 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top